Cargando…

Rescuing SLAMF3 Expression Restores Sorafenib Response in Hepatocellular Carcinoma Cells through the Induction of Mesenchymal-to-Epithelial Transition

SIMPLE SUMMARY: Sorafenib is a treatment for advanced HCC which demonstrated a poor objective response rate due to important induction of resistance. We demonstrated that induction of acquired-resistance to sorafenib in Huh-7 cell line leads to the loss of SLAMF3 expression, a tumor suppressor recep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fouquet, Grégory, Marié, Constance, Collet, Louison, Vilpoux, Catherine, Ouled-Haddou, Hakim, Nguyen-Khac, Eric, Bayry, Jagadeesh, Naassila, Mickaël, Marcq, Ingrid, Bouhlal, Hicham
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869973/ https://www.ncbi.nlm.nih.gov/pubmed/35205659 http://dx.doi.org/10.3390/cancers14040910

Ejemplares similares

Hepatocyte SLAMF3 reduced specifically the multidrugs resistance protein MRP-1 and increases HCC cells sensitization to anti-cancer drugs
por: Fouquet, Grégory, et al.
Publicado: (2016)

Mechanisms of chronic alcohol exposure-induced aggressiveness in cellular model of HCC and recovery after alcohol withdrawal
por: Marié, Constance, et al.
Publicado: (2022)

RB/PLK1-dependent induced pathway by SLAMF3 expression inhibits mitosis and control hepatocarcinoma cell proliferation
por: Bouhlal, Hicham, et al.
Publicado: (2016)

Signaling lymphocytic activation molecules Slam and cancers: friends or foes?
por: Fouquet, Gregory, et al.
Publicado: (2018)

Identification of SLAMF3 (CD229) as an Inhibitor of Hepatocellular Carcinoma Cell Proliferation and Tumour Progression
por: Marcq, Ingrid, et al.
Publicado: (2013)

The Expression of the Hepatocyte SLAMF3 (CD229) Receptor Enhances the Hepatitis C Virus Infection
por: Cartier, Flora, et al.
Publicado: (2014)

A Combination of Cytokines Rescues Highly Purified Leukemic CLL B-Cells from Spontaneous Apoptosis In Vitro
por: Ghamlouch, Hussein, et al.
Publicado: (2013)

PB1769: STIM2, A CALCIUM CENSOR POTENTIALLY INVOLVED IN THE PATHOPHYSIOLOGY OF ACUTE MYELOID LEUKEMIA
por: Djordjevic, Stefan, et al.
Publicado: (2023)

Negative Regulation of Humoral Immunity Due to Interplay between the SLAMF1, SLAMF5, and SLAMF6 Receptors
por: Wang, Ninghai, et al.
Publicado: (2015)

Histone Deacetylases Function in the Control of Early Hematopoiesis and Erythropoiesis
por: Vong, Pascal, et al.
Publicado: (2022)

CRISPR-Mediated Triple Knockout of SLAMF1, SLAMF5 and SLAMF6 Supports Positive Signaling Roles in NKT Cell Development
por: Huang, Bonnie, et al.
Publicado: (2016)

Responses to Microbial Challenges by SLAMF Receptors
por: van Driel, Boaz Job, et al.
Publicado: (2016)

Migration of Myeloid Cells during Inflammation Is Differentially Regulated by the Cell Surface Receptors Slamf1 and Slamf8
por: Wang, Guoxing, et al.
Publicado: (2015)

Ascorbic acid (vitamin C) synergistically enhances the therapeutic effect of targeted therapy in chronic lymphocytic leukemia
por: Darwiche, Walaa, et al.
Publicado: (2020)

CRISPR-Mediated Slamf1(Δ/Δ) Slamf5(Δ/Δ) Slamf6(Δ/Δ) Triple Gene Disruption Reveals NKT Cell Defects but Not T Follicular Helper Cell Defects
por: Hu, Joyce K., et al.
Publicado: (2016)

SLAMF6 compartmentalization enhances T cell functions
por: Gartshteyn, Yevgeniya, et al.
Publicado: (2022)

SLAMF6 clustering is required to augment T cell activation
por: Dragovich, Matthew A., et al.
Publicado: (2019)

Treatment of multiple myeloma with the immunostimulatory SLAMF7 antibody elotuzumab
por: Einsele, Hermann, et al.
Publicado: (2016)

Clinical impact of serum soluble SLAMF7 in multiple myeloma
por: Ishibashi, Mariko, et al.
Publicado: (2018)

Emerging viral diseases of livestock in the developing world
por: Bayry, Jagadeesh
Publicado: (2013)

Regulatory T cells as adjuvant target for enhancing the viral disease vaccine efficacy
por: Bayry, Jagadeesh
Publicado: (2013)

The Measles Virus Receptor SLAMF1 Can Mediate Particle Endocytosis
por: Gonçalves-Carneiro, Daniel, et al.
Publicado: (2017)

Clinical potential of SLAMF7 antibodies – focus on elotuzumab in multiple myeloma
por: Friend, Reed, et al.
Publicado: (2017)

SLAMF6 is associated with the susceptibility and severity of rheumatoid arthritis in the Chinese population
por: Xia, Guodong, et al.
Publicado: (2022)

SLAMF7 regulates the inflammatory response in macrophages during polymicrobial sepsis
por: Wu, Yongjian, et al.
Publicado: (2023)

SLAMF7 as a Promising Immunotherapeutic Target in Multiple Myeloma Treatments
por: Chu, Emily, et al.
Publicado: (2023)

Binge Eating, But Not Other Disordered Eating Symptoms, Is a Significant Contributor of Binge Drinking Severity: Findings from a Cross-Sectional Study among French Students
por: Rolland, Benjamin, et al.
Publicado: (2017)

Modulation of HIV Binding to Epithelial Cells and HIV Transfer from Immature Dendritic Cells to CD4 T Lymphocytes by Human Lactoferrin and its Major Exposed LF-33 Peptide
por: Carthagena, Laetitia, et al.
Publicado: (2011)

SAP-Dependent and -Independent Regulation of Innate T Cell Development Involving SLAMF Receptors
por: De Calisto, Jaime, et al.
Publicado: (2014)

Cancer cell-expressed SLAMF7 is not required for CD47-mediated phagocytosis
por: He, Yuan, et al.
Publicado: (2019)

SLAMF1 Promotes Methotrexate Resistance via Activating Autophagy in Choriocarcinoma Cells
por: Shi, Dazun, et al.
Publicado: (2020)

SLAMF Receptor Expression Identifies an Immune Signature That Characterizes Systemic Lupus Erythematosus
por: Humbel, Morgane, et al.
Publicado: (2022)

Autoimmune and inflammatory diseases following COVID-19
por: Galeotti, Caroline, et al.
Publicado: (2020)

High risk of autoimmune diseases after COVID-19
por: Sharma, Chetan, et al.
Publicado: (2023)

SLAMF1 contributes to cell survival through the AKT signaling pathway in Farage cells
por: Yoon, Heejei, et al.
Publicado: (2020)

Evidence for the loss and recovery of SLAMF9 during human evolution: implications on Dollo’s law
por: Murphy, Maegan K., et al.
Publicado: (2021)

Advances in Understanding the Roles of CD244 (SLAMF4) in Immune Regulation and Associated Diseases
por: Sun, Lin, et al.
Publicado: (2021)

SLAMF8 expression predicts the efficacy of anti‐PD1 immunotherapy in gastrointestinal cancers
por: Zhang, Qun, et al.
Publicado: (2021)

SLAMF7 modulates B cells and adaptive immunity to regulate susceptibility to CNS autoimmunity
por: O’Connell, Patrick, et al.
Publicado: (2022)

TLR9 Ligand (CpG Oligodeoxynucleotide) Induces CLL B-Cells to Differentiate into CD20(+) Antibody-Secreting Cells
por: Ghamlouch, Hussein, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_j98go2v4opa8oji84mublc4d8d